1. Adverse event reporting: serious AEs coded as nonserious

   News item 30 January 2016 Pages: 1 - 1

2. Nasal corticosteroids prescription-only for <18 years in Denmark

   News item 30 January 2016 Pages: 2 - 2

3. PRAC adopts new PV strategy at Jan 2016 meeting

   News item 30 January 2016 Pages: 3 - 3

4. Sales of Avastin halted in two states in India: reduced vision

   News item 30 January 2016 Pages: 4 - 4

5. Suvorexant signals: ineffective, sleep disturbance, agitation

   News item 30 January 2016 Pages: 5 - 5

6. UK experts seek details on French trial leading to brain damage

   News item 30 January 2016 Pages: 6 - 6

7. US FDA fails to adequately monitor expedited drugs post-launch

   News item 30 January 2016 Pages: 7 - 7

8. Antidepressants increase risk of cerebral microbleeds

   Clinical study 30 January 2016 Pages: 8 - 8

9. Bleeding risks with VKAs compared in very old patients

   Clinical study 30 January 2016 Pages: 9 - 9

10. Clarithromycin increases short-term cardiovascular risks

    Clinical study 30 January 2016 Pages: 10 - 10

11. New-onset depression linked to prolonged opioid use, not dose

    Clinical study 30 January 2016 Pages: 11 - 11

12. Paroxetine use in first trimester increases risk of abnormalities

    Clinical study 30 January 2016 Pages: 12 - 12

13. Statin use increases risk of acute and chronic kidney disease

    Clinical study 30 January 2016 Pages: 13 - 13

14. Abacavir/dolutegravir/lamivudine

    Case report 30 January 2016 Pages: 14 - 14

15. Abatacept

    Case report 30 January 2016 Pages: 15 - 15

16. Aciclovir/valaciclovir

    Case report 30 January 2016 Pages: 16 - 16

17. Adalimumab

    Case report 30 January 2016 Pages: 18 - 18

18. Adalimumab

    Case report 30 January 2016 Pages: 19 - 19

19. Adalimumab

    Case report 30 January 2016 Pages: 20 - 20

20. Adalimumab

    Case report 30 January 2016 Pages: 21 - 21

21. Adalimumab

    Case report 30 January 2016 Pages: 22 - 22

22. Adalimumab/certolizumab pegol/infliximab

    Case report 30 January 2016 Pages: 23 - 23

23. Adalimumab/etanercept

    Case report 30 January 2016 Pages: 24 - 24

24. Adalimumab/methotrexate

    Case report 30 January 2016 Pages: 25 - 25

25. Adalimumab/methotrexate/methylprednisolone

    Case report 30 January 2016 Pages: 26 - 26

26. Afatinib

    Case report 30 January 2016 Pages: 27 - 27

27. Albendazole

    Case report 30 January 2016 Pages: 28 - 28

28. Alemtuzumab

    Case report 30 January 2016 Pages: 29 - 29

29. Alendronic acid

    Case report 30 January 2016 Pages: 30 - 30

30. Alosetron

    Case report 30 January 2016 Pages: 31 - 31

31. Alprazolam/metamfetamine/opioid analgesics

    Case report 30 January 2016 Pages: 32 - 32

32. Amiodarone/simvastatin

    Case report 30 January 2016 Pages: 33 - 33

33. Amoxicillin/clavulanic-acid

    Case report 30 January 2016 Pages: 34 - 34

34. Amphotericin B

    Case report 30 January 2016 Pages: 35 - 35

35. Amphotericin B liposomal

    Case report 30 January 2016 Pages: 36 - 36

36. Anakinra

    Case report 30 January 2016 Pages: 37 - 37

37. Antibacterials

    Case report 30 January 2016 Pages: 38 - 38

38. Antibacterials/immune-globulin

    Case report 30 January 2016 Pages: 39 - 39

39. Antiepileptic drugs

    Case report 30 January 2016 Pages: 40 - 40

40. Antihypertensives

    Case report 30 January 2016 Pages: 41 - 41

41. Antineoplastics

    Case report 30 January 2016 Pages: 42 - 42

42. Antineoplastics

    Case report 30 January 2016 Pages: 43 - 43

43. Antineoplastics

    Case report 30 January 2016 Pages: 44 - 44

44. Antineoplastics

    Case report 30 January 2016 Pages: 45 - 45

45. Antineoplastics/zoledronic acid/silver nitrate

    Case report 30 January 2016 Pages: 46 - 46

46. Antituberculars

    Case report 30 January 2016 Pages: 47 - 47

47. Antituberculars/disease-modifying antirheumatics/nonsteroidal anti-inflammatories

    Case report 30 January 2016 Pages: 48 - 48

48. Artemether/lumefantrine

    Case report 30 January 2016 Pages: 49 - 49

49. Aspirin/heparin/prasugrel

    Case report 30 January 2016 Pages: 50 - 50

50. Asunaprevir/daclatasvir

    Case report 30 January 2016 Pages: 51 - 51